ArticleBreast cancer research and treatment2017

Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.

Elena Strekalova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.